Role of AIM2, a selected target gene of microsatellite instability, in the pathogenesis of DNA mismatch repair-deficient colon cancers
Role of AIM2, a selected target gene of microsatellite instability, in the pathogenesis of DNA mismatch repair-deficient colon cancers
批准号:
24817972
负责人:
Dr. Johannes F Gebert
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2006
资助国家:
德国
项目状态:
已结题
起止时间:
2005-12-31 至 2008-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Genetic instability and accumulation of mutations is a major characteristic of malignant tumors. In colon cancer, the type and spectrum of affected genes markedly differs between chromosomal unstable (CIN) and microsatellite unstable (MSI) tumors. In CIN tumors the most frequently mutated growth regulating genes have been well characterized as members of signaling pathways, whereas the pathways of carcinogenesis in MSI tumors are largely unknown. In consequence of a defective mismatch repair system, MSI tumors accumulate frameshift mutations in multiple genes harboring repetitive DNA sequences, only a subset of which is expected to promote cancer progression. By using a statistical model that we recently proposed to predict mutations with functional impact on MSI tumors, we identified 26 candidate tumor suppressor genes, 20 of which were previously not reported to be involved in colon carcinogenesis. One candidate gene - AIM2 (absent in melanoma 2) - belongs to the HIN-200 family of interferon-inducible genes which mediate growth inhibition in a variety of different cell types. The biologic function of AIM2 in colon cells however, is unknown so far. Our frameshift mutation analyses of the cMS sequence in AIM2 revealed mutations in more than 50% of MSI colorectal adenomas and carcinomas. Notably, we detected a high frequency of AIM2 biallelic mutations (>40%) indicating complete loss of function in MSI colon cell lines and primary MSI colon carcinomas and adenomas, albeit at lower frequency. Preliminary data suggest that AIM2 causes cell death when transiently expressed in AIM2 deficient MSI colon cancer cell lines. We here propose to characterize AIM2 function and to analyse its impact on the pathogenesis of MSI cancers. Detailed understanding of AIM2 function might help to improve diagnostic and therapy of this aggressively growing cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MSI-target gene-dependent alterations of cell surface glycosylation signatures in MSI colorectal cancer cell lines and primary tumors
-
批准号:148215620
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Dr. Johannes F Gebert
-
依托单位:
国内基金
海外基金
登录
查看更多内容
融合图神经网络与多模态学习的骨癌痛中枢敏化机制解析及AIM2/STING靶向药物多属性优化算法研究
-
批准号:JCZRMS202602526
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
AIM2/PYHIN1/MNDA介导EVs-mtDNA所致的
细胞泛凋亡在类风湿关节炎软骨破坏中
的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:祁伟仲
-
依托单位:
人参皂苷Rg1调控AIM2介导cGAS/STING通路抑制NSCLC进展的作用机制
-
批准号:2025JJ80154
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吴石威
-
依托单位:
TSPAN1介导的自噬依赖性外泌体通过调控TRIM25/AIM2信号通路促进前列腺癌恶性进展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:赵旭东
-
依托单位:
miR-219a/AIM2介导血管平滑肌细胞表型转化在胸主动脉瘤/夹层中的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陆琳
-
依托单位:
KAT2B乙酰化修饰AIM2抑制乳腺癌的机制研究
-
批准号:JCZRLH202500021
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
巨噬细胞AIM2炎性小体在心肌梗死后心室重构中的作用及机制研究
-
批准号:2025JJ70444
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:聂大安
-
依托单位:
AIM2调控巨噬细胞代谢重编程促进其M2极化进而改善毛细胞损伤的机制研究
-
批准号:2025JJ60580
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李葳
-
依托单位:
基于cGAS/STING/AIM2通路探讨活血通络丸改善急性心肌梗死后心肌损伤的机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:徐雪娟
-
依托单位: